Monthly Archives: June 2021

Prevalence of contact allergies in the population compared to a tertiary referral patch test clinic in Jena/Germany

CONCLUSIONS: Results are quite similar, although prevalences are usually higher in the clinical setting, with the exception of p-tert-butylphenol formaldehyde resin. This article is protected by copyright. All rights reserved. Continue reading






Comments Off on Prevalence of contact allergies in the population compared to a tertiary referral patch test clinic in Jena/Germany

Juvenile and adult vulvar pemphigoid, an under recognized entity: Case series of fourteen patients

No abstract Continue reading






Comments Off on Juvenile and adult vulvar pemphigoid, an under recognized entity: Case series of fourteen patients

Prevalence of adult atopic dermatitis in the general population, with a focus on moderate to severe disease: results from the Lifelines Cohort Study

Previous epidemiologic studies on atopic dermatitis (AD) indicate a large variation (0.3-17.6%) in the prevalence of adult AD, depending on differences in the methodology, AD definitions and study population^(1,2) . Here, we conducted a large cross-sectional study to firstly estimate the prevalence of adult AD in the Dutch general population, with a focus on moderate to severe AD. Continue reading






Comments Off on Prevalence of adult atopic dermatitis in the general population, with a focus on moderate to severe disease: results from the Lifelines Cohort Study

Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry

CONCLUSION: When considering the favorable scores on other PROMs and the TSQM v. II, and comparing these to the relatively low percentage of patients perceiving control according to the ADCT, interpretability of eczema control still appears difficult. Treatment satisfaction in the studied cohort was high. Continue reading






Comments Off on Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry